Farnum Rhonda 4
4 · Theravance Biopharma, Inc. · Filed Dec 5, 2025
Insider Transaction Report
Form 4
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Transactions
- Sale
Ordinary Shares
2025-12-03$18.75/sh−7,767$145,630→ 300,995 total - Sale
Ordinary Shares
2025-12-03$18.75/sh−7,766$145,619→ 293,229 total - Sale
Ordinary Shares
2025-12-03$18.75/sh−15,534$291,252→ 277,695 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices from $18.52 to $18.94 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.